Item Brochure
REFERENCES
1. Braunstein GD, Rasor J, Adler D, Danzer H, Wade ME. Serum chorionic gonadotropin levels throughout
normal pregnancy. Am J Obstet Gynecol 1976; 126:678 – 681.
2. Kadar N, Devore G, Romero R. Discriminatory hCG Zone: Its Use in the Sonographic Evaluation for
Ectopic Pregnancy. Obstet Gyneco/1981;58:156 – 61.
3. Kadar N, Caldwell BV, Romero R. A Method of Screening for Ectopic Pregnancy and Its Indications.
Obstet Gyneco/1981;58:162 – 6.
4. Cole LA. Phantom hCG and Phantom Choriocarcinoma. GynecoIOnco/ 1998; 71:325 – 9.
5. Hussa RO. The Clinical Marker hCG, Westport, CT: Praeger Publishers. 1987:137 – 50.
6. Mishalani SH, Seliktar J, Braunstein GD. Four Rapid Serum - Urine Combination Assays of
Choriogonadotropin (hCG) Compared and Assessed for their Utility in Quantitative
Determinations of hCG. Clin Chem 1994;40/10, 1944 – 9.
7. Hussa RO, Rinke ML, Schweitzer PG. Discordant Human Chorionic Gonadotropin Results: Causes and
Solutions. Obstet Gyneco/1985;65:211 – 9.
8. Boscato LM, and Stuart MC. Heterophilic Antibodies: A Problem for All Immunoassays. Clin Chem
1988;34:27 – 33.
9. Braunstein GD, Vaitukaitis JL, Carbone PP, Ross GT. Ectopic Production of Human Chorionic
Gonadotropin by Neoplasms. Ann Intern Med 1973;78:39 – 45.
10. Hussa RO. Clinical Utility of Human Chorionic Gonadotropin and -Subunit Measurements. Obstet
Gyneco/1982;60:1 – 12.
11. Primus FJ, Kelly EA, Hansen HJ, Goldenberg DM. “Sandwich” – Type Immunoassay of Carcinoembryonic
Antigen in Patients Receiving Murine Monoclonal Antibodies for Diagnosis and Therapy. Clin Chem
1988;34:261 – 4.
12. Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan Jr AC. Human Anti-Murine Immunoglobulin
Responses in Patients Receiving Monoclonal Antibody Therapy. Cancer Res 1985;45:879 – 85.
13. Wilcox AJ, Weinberg CR, O’Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC.
Incidence of Early Loss of Pregnancy. N Engl J Med 1988;319:189 – 94.
14. Alfthan H, Haglund C, Dabek J, Stenman U – H. Concentrations of Human Choriogonadotropin,
Its – Subunit, and the Core Fragment of the – Subunit in Serum and Urine of Men and Nonpregnant
Women. Clin Chem 1992;38:1981 – 7.
15. Borkowski A, Muquardt C. Human Chorionic Gonadotropin in the Plasma of Normal, Nonpregnant
Subjects. N Engl J Med 1979;301:298 – 302.
16. Hussa RO. The Clinical Marker hCG, Westport, CT: Praeger Publishers. 1987:77 – 95.
17. Donald S. Young (ed). Effects of Drugs on Clinical Laboratory Tests, Volume 1, 5th Edition, Philadelphia,
PA, AACC Press (2000).
18. Lenton EA, Neal LM, Sulaiman R. Plasma concentrations of human chorionic gonadotropin from the
time of implantation until the second week of pregnancy. Fertil Steril 1982; 37:773 – 778.
19. Armstrong EG, Ehrlich PH, Birken S, Schlatterer JP, Siris E, Hembree WC, Canfield RE. Use of a highly
sensitive and specific immunoradiometric assay for detection of human chorionic gonadotropin
in urine of normal, non-pregnant individuals. J Clin Endocrinol Metab 1984; 58:867 – 874.
ASSISTANCE
For assistance, call Sekisui Diagnostics Technical Service at 800-332-1042.
REORDER
No. 124 (25 tests)
TRADEMARK
OSOM
®
is a registered U.S. trademark of Sekisui Diagnostics, LLC.
Coat-A-Count
®
is a registered trademark of Diagnostic Products Corporation.
QuickVue
®
is a registered trademark of Quidel Corporation.
Licensed under U.S. Patent Nos. 5,714,389; 5,989,921 and 6,485,982 and related non-U.S. patents
and patent applications.
MANUFACTURED BY
Sekisui Diagnostics, LLC 6659 Top Gun Street, San Diego, CA 92121 USA
© 2012 Sekisui Diagnostics, LLC – All rights reserved.
Tel: 800-332-1042
www.sekisuidiagnostics.com